Ciprofloxacin 5% dextrose, injection, 400MG/200ML, (2MG/ML) is a medical countermeasure (MCM) required by the SNS

Ended Awarded Last action

Contract number
75A50322F80029
Awardee
Awarding agency
Obligated
$47,750,653

Award facts

Contract value 100% obligated
$47,750,653.44 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Hoffman Estates, IL 60195, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Change Order P00004 $0
Supplemental Agreement for work within scope P00003 $0
Other Administrative Action P00002 $0
Supplemental Agreement for work within scope P00001 $0
Original award $47,750,653

About this award

This federal contract award is for the delivery of CIPROFLOXACIN 5% DEXTROSE, INJECTION, 400MG/200ML, (2MG/ML), a medical countermeasure (MCM) required by the Strategic National Stockpile (SNS). The contract was awarded to Sagent Pharmaceuticals, Inc., a specialty and generic pharmaceutical manufacturer, under the General Services Administration (GSA) Pharmaceutical and Drugs Federal Supply Schedule. The contract has a ceiling value of $47,750,653.44 and is a Firm Fixed Price Delivery Order with a period of performance through December 31, 2024. The contract was awarded by the Office of the Assistant Secretary for Preparedness and Response, which is a civilian agency within the Department of Health and Human Services. This award is not set aside for any special business categories. Sagent Pharmaceuticals, Inc. is the prime contractor and has a manufacturing facility in Hoffman Estates, Illinois that serves as the primary place of performance.

Quick answers

Who was awarded contract 75A50322F80029?

75A50322F80029 was awarded to Sagent Pharmaceuticals, Inc. by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 26, 2022.

How much is contract 75A50322F80029 worth?

The government has obligated $47,750,653 on 75A50322F80029.

Is contract 75A50322F80029 an order under another contract?

Yes. 75A50322F80029 is a delivery order under V797D40094, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 75A50322F80029 competed?

The extent of competition for 75A50322F80029 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award